MEDCL — Medincell SA Cashflow Statement
0.000.00%
Last trade - 00:00- €1.12bn
- €1.11bn
- €25.42m
Annual cashflow statement for Medincell SA, fiscal year end - March 31st, EUR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19 | -24.8 | -32 | -25 | -18.4 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 4.92 | 4.29 | 12.4 | 8.31 | 11.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.625 | -2.37 | -3.04 | 3.09 | 24.4 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -12.1 | -21.4 | -21 | -11.9 | 19.5 |
| Capital Expenditures | -0.819 | -1.97 | -1.03 | -1.19 | -1.66 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.243 | 1.66 | 2.33 | 0.578 | -11.6 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.06 | -0.316 | 1.3 | -0.613 | -13.2 |
| Financing Cash Flow Items | -3.5 | -1.13 | -4.46 | -2.15 | -1.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 47.9 | -0.8 | 1.56 | 25.5 | 33.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 34.7 | -22.5 | -18.1 | 13 | 39.6 |